XTL Biopharmaceuticals Statistics
NASDAQ: XTLBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.99+0.01 (+0.51%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
XTL Biopharmaceuticals by the numbers
XTL Biopharmaceuticals has a market capitalization of $4.9 million based on 2.46M shares outstanding. With trailing EPS of $-0.36, XTL Biopharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.0% below its 50-day average and 28.8% below its 200-day average.
Average daily trading volume is 8.49K shares, or about $16,889 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XTLB valuation vs. peer median
| Metric | XTLB | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.89M | $5.11M | -4% |
| Avg. volume | 8.49K | 310.72K | -97% |
Peer median across 8 companies: XBIO, LNAI, RDHL, NCNA, PPCB, DRMA, BGMS, ENLV.
Valuation
- Market cap
- $4.89M
- EPS (TTM)
- $-0.36
- Shares outstanding
- 2.46M
Price and trading
- Previous close
- 1.98
- Open
- 1.98
- Day range
- 1.97 – 2.03
- 52-week range
- 1.97 – 7.44
- Beta
- —
- Volume
- 13.56K
- Average volume
- 8.49K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 4.89M
- Eps
- -0.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.44
- Week52 Low
- 1.97
- Avg Volume
- 8,487.00
- Shares Outstanding
- 2.46M
- Ma50
- 2.55
- Ma200
- 2.80
- Pct From52w High
- -73.25%
- Pct From52w Low
- 1.02%